| U S PHYSICAL THERAPY INC /NV (USPH) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | |
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | |
| Price to Sales | 1.61x | 1.52x | 1.70x | 1.63x | 1.58x | 2.00x | 1.98x | 2.22x | 2.77x | 2.32x | 2.33x | 2.73x | 2.24x | 1.91x | 1.83x | 2.66x | 2.51x | 2.49x | 2.96x | 3.17x | 3.13x | 3.61x | 2.61x | 2.38x | 1.85x | 3.03x | 3.52x | 3.30x | 2.90x | 2.85x | 3.37x | 2.80x | 2.44x | 2.20x | 1.96x | ||||||||||||||
| Price to Book | 2.64x | 2.49x | 2.57x | 2.37x | 2.22x | 2.74x | 2.64x | 2.87x | 3.53x | 2.94x | 2.80x | 3.25x | 4.01x | 3.34x | 3.12x | 4.57x | 4.29x | 4.17x | 4.98x | 5.27x | 4.85x | 5.60x | 4.21x | 4.07x | 3.66x | 6.08x | 7.13x | 6.82x | 6.10x | 5.99x | 7.09x | 5.77x | 5.00x | 4.44x | 3.90x | ||||||||||||||
| Price to Earnings | 31.73x | 30.01x | 28.95x | 31.11x | 33.17x | 42.69x | 55.91x | 54.69x | 58.68x | 49.59x | 45.60x | 52.02x | 41.43x | 32.82x | 24.92x | 34.92x | 31.11x | 30.22x | 33.09x | 33.59x | 31.62x | 43.97x | 37.10x | 36.81x | 27.09x | 36.47x | 39.48x | 37.60x | 37.02x | 37.10x | 47.19x | 42.32x | 42.16x | 40.84x | 48.40x | ||||||||||||||
| Price to Unlevered FCF | 16.73x | 15.82x | 18.60x | 16.56x | 16.76x | 17.90x | 15.50x | 18.18x | 22.58x | 17.08x | 19.00x | 22.72x | 21.89x | 18.03x | 17.34x | 20.54x | 18.33x | 16.15x | 16.81x | 17.16x | 13.22x | 15.48x | 12.33x | 12.64x | 13.54x | 23.38x | 25.64x | 22.01x | 18.86x | 17.72x | 21.54x | 18.80x | |||||||||||||||||
| Debt to Asset Ratio | .36x | .35x | .35x | .36x | .35x | .35x | .35x | .34x | .35x | .34x | .34x | .44x | .44x | .42x | .42x | .40x | .40x | .32x | .26x | .24x | .31x | .30x | .33x | .44x | .29x | .34x | .34x | .31x | .21x | .25x | .25x | .24x | .26x | .48x | .50x | .50x | .46x | .45x | .46x | .48x | .43x | .44x | .44x | .44x | .29x | .31x | .31x | .31x | |
| Current Ratio | 1.01x | 1.20x | 1.18x | 1.17x | 1.18x | 1.78x | 1.88x | 2.16x | 2.28x | 2.77x | 2.82x | 1.30x | 1.30x | 1.39x | 1.43x | 1.08x | 1.14x | .97x | 1.06x | .83x | .94x | .89x | 1.05x | 2.09x | 1.41x | 1.47x | 1.88x | 1.18x | 1.89x | 1.93x | 2.06x | 1.67x | 1.95x | 2.04x | 2.26x | 2.31x | 2.68x | 2.56x | 2.45x | 2.83x | 3.17x | 2.98x | 2.56x | 2.61x | 2.15x | 2.59x | 2.27x | 2.80x | |